Cognition Therapeutics's total assets for Q3 2025 were $43.40M, an increase of 121.15% from the previous quarter. CGTX total liabilities were $6.87M for the fiscal quarter, a -45.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.